JP2006517195A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006517195A5 JP2006517195A5 JP2005501483A JP2005501483A JP2006517195A5 JP 2006517195 A5 JP2006517195 A5 JP 2006517195A5 JP 2005501483 A JP2005501483 A JP 2005501483A JP 2005501483 A JP2005501483 A JP 2005501483A JP 2006517195 A5 JP2006517195 A5 JP 2006517195A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- val
- compound according
- allo
- ile
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/GB2002/004735 WO2003033012A1 (en) | 2001-10-19 | 2002-10-18 | Kahalalide compounds for use in cancer therapy |
| GBGB0304367.6A GB0304367D0 (en) | 2003-02-26 | 2003-02-26 | Methods for treating psoriasis |
| GB0314725A GB0314725D0 (en) | 2003-06-24 | 2003-06-24 | New antitumoral compounds |
| PCT/US2003/033207 WO2004035613A2 (en) | 2002-10-18 | 2003-10-20 | 4-methylhexanoic kahalaide f compound |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2006517195A JP2006517195A (ja) | 2006-07-20 |
| JP2006517195A5 true JP2006517195A5 (https=) | 2006-12-21 |
| JP4430009B2 JP4430009B2 (ja) | 2010-03-10 |
Family
ID=32110555
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2005501483A Expired - Fee Related JP4430009B2 (ja) | 2002-10-18 | 2003-10-20 | 新規な抗腫瘍化合物 |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP1572726B1 (https=) |
| JP (1) | JP4430009B2 (https=) |
| CN (2) | CN101077885A (https=) |
| BR (1) | BR0315489A (https=) |
| MX (1) | MXPA05004133A (https=) |
| NZ (1) | NZ539093A (https=) |
| WO (1) | WO2004035613A2 (https=) |
| ZA (1) | ZA200502926B (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6274551B1 (en) * | 1994-02-03 | 2001-08-14 | Pharmamar, S.A. | Cytotoxic and antiviral compound |
| GB0304367D0 (en) * | 2003-02-26 | 2003-04-02 | Pharma Mar Sau | Methods for treating psoriasis |
| US7507708B2 (en) | 2003-02-26 | 2009-03-24 | Pharma Mar, S.A.U. | Antitumoral compounds |
| GB0321066D0 (en) | 2003-09-09 | 2003-10-08 | Pharma Mar Sau | New antitumoral compounds |
| WO2009052379A2 (en) * | 2007-10-19 | 2009-04-23 | Pharma Mar, S.A. | Improved antitumoral treatments |
| DE102008005097B4 (de) * | 2008-01-18 | 2011-04-07 | Leibnitz-Institut für Meereswissenschaften | Antitumoraler Cyclodepsipeptide, deren Herstellung und Verwendung |
| EP2262522A1 (en) * | 2008-03-07 | 2010-12-22 | Pharma Mar, S.A. | Improved antitumoral treatments |
| WO2009135939A2 (en) * | 2008-05-09 | 2009-11-12 | Pharma Mar, S.A. | Depsipeptide for use in cancer therapy |
| RS54648B1 (sr) | 2010-11-12 | 2016-08-31 | Pharma Mar S.A. | Kombinovana terapija sa antitumorskim alkaloidom |
| KR102491180B1 (ko) | 2017-04-27 | 2023-01-20 | 파르마 마르 에스.에이. | 항종양 화합물 |
| PE20252386A1 (es) | 2019-11-21 | 2025-10-10 | Pharma Mar Sa | Metodo de tratamiento del cancer de pulmon de celulas pequenas con formulaciones de lurbinectedina |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6178719A (ja) * | 1984-09-25 | 1986-04-22 | Tanabe Seiyaku Co Ltd | 総合輸液剤 |
| GB9302046D0 (en) * | 1993-02-03 | 1993-03-24 | Pharma Mar Sa | Antiumoral compound-v |
| US6274551B1 (en) * | 1994-02-03 | 2001-08-14 | Pharmamar, S.A. | Cytotoxic and antiviral compound |
| NZ525243A (en) * | 2000-10-31 | 2005-01-28 | Pharma Mar S | A lyophilised formulation comprising kahalalide F, a peptide isolated from a herbivorous marine species of mollusc, Elysia rufescens, to treat cancer |
| EP1435990A1 (en) * | 2001-10-19 | 2004-07-14 | Pharma Mar, S.A. | Kahalalide compounds for use in cancer therapy |
-
2003
- 2003-10-20 EP EP03779140A patent/EP1572726B1/en not_active Expired - Lifetime
- 2003-10-20 MX MXPA05004133A patent/MXPA05004133A/es active IP Right Grant
- 2003-10-20 BR BR0315489-0A patent/BR0315489A/pt not_active IP Right Cessation
- 2003-10-20 WO PCT/US2003/033207 patent/WO2004035613A2/en not_active Ceased
- 2003-10-20 JP JP2005501483A patent/JP4430009B2/ja not_active Expired - Fee Related
- 2003-10-20 CN CNA2007101122538A patent/CN101077885A/zh active Pending
- 2003-10-20 NZ NZ539093A patent/NZ539093A/en not_active IP Right Cessation
- 2003-10-20 CN CN200380101647A patent/CN100591691C/zh not_active Expired - Fee Related
-
2005
- 2005-04-11 ZA ZA200502926A patent/ZA200502926B/xx unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2468021C2 (ru) | Гетероциклические соединения и их применение | |
| JP2010528026A5 (https=) | ||
| JP2021063088A5 (https=) | ||
| JP2015506376A5 (https=) | ||
| JP2003532731A5 (https=) | ||
| CN108348523A (zh) | 包含pi3k抑制剂和hdac抑制剂的组合物 | |
| JP2024133474A5 (https=) | ||
| ES2269769T3 (es) | Terapia de combinacion ee comprende zd6474 y un taxano. | |
| JP2006523216A5 (https=) | ||
| US11065240B2 (en) | Drug combinations to treat multiple myeloma | |
| WO2017151425A1 (en) | Hsp90 inhibitor drug conjugates | |
| JP2006517195A5 (https=) | ||
| JP2010241830A5 (https=) | ||
| JP2008535902A5 (https=) | ||
| JP2008521928A5 (https=) | ||
| JP2009537498A5 (https=) | ||
| ATE358668T1 (de) | Drogen zur behandlung maligner tumoren | |
| JP2020534300A5 (https=) | ||
| JP2022541938A5 (https=) | ||
| JP2014512355A5 (https=) | ||
| EP1458734A4 (en) | ISOINDIGO, INDIGO AND INDIRUBIN DERIVATIVES AND THEIR USE IN THE TREATMENT OF CANCER | |
| JP2006502132A5 (https=) | ||
| JP2023503167A5 (https=) | ||
| JP2011509306A5 (https=) | ||
| JP2023500857A (ja) | 新規な化合物およびそれを含むがんの予防または治療用薬学組成物 |